Tandem Diabetes Care Inc
F:TD5A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tandem Diabetes Care Inc
F:TD5A
|
US |
|
D
|
DBS Group Holdings Ltd
SWB:DEVL
|
SG |
|
Assystem SA
PAR:ASY
|
FR |
|
D
|
Daimler Truck Holding AG
F:DTG
|
DE |
|
E
|
Euronet Worldwide Inc
SWB:EEF
|
US |
|
UniCredit SpA
F:CRIP
|
IT |
|
H
|
Hartford Financial Services Group Inc
F:HFF
|
US |
|
A
|
ASM International NV
XMUN:AVS
|
NL |
|
Celyad Oncology SA
OTC:CLYYF
|
BE |
|
E
|
Eni SpA
DUS:ENI
|
IT |
|
T
|
Tikehau Capital SCA
F:7TI
|
FR |
Wall St Price Targets
TD5A Price Targets Summary
Tandem Diabetes Care Inc
According to Wall Street analysts, the average 1-year price target for TD5A is 23.34 EUR with a low forecast of 12.41 EUR and a high forecast of 41.61 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TD5A's stock price target?
Price Target
23.34
EUR
According to Wall Street analysts, the average 1-year price target for TD5A is 23.34 EUR with a low forecast of 12.41 EUR and a high forecast of 41.61 EUR.
What is the Revenue forecast for Tandem Diabetes Care Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Tandem Diabetes Care Inc?
Projected CAGR
17%
The compound annual growth rate for Gross Profit over the next 3 years is 17%.
